ArcticZymes Technologies ASA

Historical price data

ArcticZymes Technologies ASA is a public biotech company that develops and commercializes unique enzymes derived from organisms adapted to the extreme cold of the Arctic. Its core technology platform focuses on cold-adapted enzymes, including nucleases, polymerases, and phosphatases, which offer advantages in molecular biology, diagnostics, and next-generation sequencing workflows. The company operates both a product business for research use and a therapeutic discovery pipeline, with strategic partnerships to expand its market reach. Its mission is to translate the unique properties of Arctic biomolecules into innovative tools and potential medicines.

Proprietary platform for discovering and engineering cold-adapted enzymes from Arctic marine organisms, yielding products with high activity at low temperatures, thermolability, and salt tolerance for research, diagnostics, and therapeutics.

Total raised: $12M

Competes with giants like Thermo Fisher and New England Biolabs in the research tools market, differentiating on enzyme performance rather than scale. In therapeutics, it faces competition from other biotechs developing enzyme-based drugs, competing on the novelty of its Arctic-derived platform and specific mechanism.